Are MSI and TMB automatically included in every Precise Tumor report?

Unlock essential insights into hereditary cancer risk, diagnosis, and treatment. Study comprehensive strategies with flashcards and multiple-choice questions featuring detailed explanations. Prepare effectively for your exam!

Multiple Choice

Are MSI and TMB automatically included in every Precise Tumor report?

Explanation:
In tumor profiling, MSI and TMB are key biomarkers used to guide immunotherapy decisions. MSI reflects mismatch repair deficiency, which can predict benefit from checkpoint inhibitors, while TMB measures the overall number of somatic mutations and can correlate with immunotherapy response in several cancers. Because these biomarkers provide important, actionable information for treatment options, many platforms design their reports to include both automatically. In the Precise Tumor report, these metrics are computed and presented as part of the standard output, so clinicians receive them without needing to request them separately. This automatic inclusion ensures you have essential data on immunotherapy suitability right away.

In tumor profiling, MSI and TMB are key biomarkers used to guide immunotherapy decisions. MSI reflects mismatch repair deficiency, which can predict benefit from checkpoint inhibitors, while TMB measures the overall number of somatic mutations and can correlate with immunotherapy response in several cancers. Because these biomarkers provide important, actionable information for treatment options, many platforms design their reports to include both automatically. In the Precise Tumor report, these metrics are computed and presented as part of the standard output, so clinicians receive them without needing to request them separately. This automatic inclusion ensures you have essential data on immunotherapy suitability right away.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy